raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:508

Donohue syndrome

Type
Malformation syndrome
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Antenatal, Neonatal
Status
active

A subtype of <i>INSR</i>-related severe insulin resistance characterized by severe intrauterine growth retardation, postnatal failure to thrive, dysmorphic features, extreme insulin resistance, fluctuating blood glucose levels. The life expectancy is very short, with death usually occurring during infancy due to metabolic complications, cardiomyopathy and/or infections.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDonohue syndrome
frSyndrome de Donohue
deDonohue-Syndrom
esSíndrome de Donohue
itSindrome di Donohue
nlSyndroom van DonohueLeprechaunisme
ptLeprechaunismoSíndrome Donohue
plLeprechaunizmZespół Donohue
csLeprechaunismusDonohueova nemoc
ukЛепреконізмСиндром Донохью
zh矮妖综合征Donohue综合征
trLeprekonizmDonohue sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM246200Evalidated
ICD-10E34.8NTBTindexvalidated
ICD-115A44NTBTindexvalidated
MONDO0009517Evalidated
MeSHD056731Evalidated
UMLSC0265344Evalidated
GARD6885Evalidated
MedDRA10081896Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (6):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
INSRDisease-causing germline mutation(s) inAssessedHGNC:6091ENSG0000017110514767019p13.2insulin receptor12023989[PMID]
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—EuropeClass onlyNot yet validatedORPHANET
Prevalence at birth<1 / 1 000 000—EuropeClass onlyValidated9128805[PMID]
Point prevalence<1 / 1 000 0000.0006 / 100 000WorldwideValue and classValidated38773407[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

47 annotations · validated 2020-02-13
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0003162Fasting hypoglycemia
HP:0000962Hyperkeratosis
HP:0000998Hypertrichosis
HP:0000855Insulin resistance
HP:0008897Postnatal growth retardation
HP:0011998Postprandial hyperglycemia
HP:0003758Reduced subcutaneous adipose tissue
HP:0008846Severe intrauterine growth retardation
Frequent (79-30%)
HP:0003270Abdominal distention
HP:0000956Acanthosis nigricans
HP:0008665Clitoral hypertrophy
HP:0004325Decreased body weight
HP:0000105Enlarged kidney
HP:0002219Facial hypertrichosis
HP:0001508Failure to thrive
HP:0002240Hepatomegaly
HP:0000842Hyperinsulinemia
HP:0001639Hypertrophic cardiomyopathy
HP:0001249Intellectual disability
HP:0000065Labial hypertrophy
HP:0000040Long penis
HP:0003247Overgrowth of external genitalia
HP:0004405Prominent nipples
HP:0004914Recurrent infantile hypoglycemia
HP:0011344Severe global developmental delay
HP:0003202Skeletal muscle atrophy
Occasional (29-5%)
HP:0008936Axial hypotonia
HP:0011787Central hypothyroidism
HP:0100879Enlarged ovaries
HP:0002150Hypercalciuria
HP:0000974Hyperextensible skin
HP:0000316Hypertelorism
HP:0002900Hypokalemia
HP:0000859Increased circulating aldosterone concentration
HP:0000848Increased circulating renin level
HP:0001176Large hands
HP:0001833Long foot
HP:0000369Low-set ears
HP:0025024Megarectum
HP:0000252Microcephaly
HP:0000121Nephrocalcinosis
HP:0000307Pointed chin
HP:0000411Protruding ear
HP:0002035Rectal prolapse
HP:0012471Thick vermilion border
HP:0001072Thickened skin
HP:0000445Wide nose

Run the differential on the 8 obligate / very frequent terms

Annotation source: 29369573[PMID]_31840185[PMID]_29148123[PMID]

7

Sources for this card